The field of nanotechnology has revolutionised global attempts to prevent, treat, and
eradicate infectious diseases in the foreseen future. Nanovaccines have proven to be a …

Vaccination is still the most cost-effective way to combat infectious illnesses. Conventional
vaccinations may have low immunogenicity and, in most situations, only provide partial …

The respiratory mucosa is the primary portal of entry for numerous viruses such as the
respiratory syncytial virus, the influenza virus and the parainfluenza virus. These pathogens …

Nanomaterials (NMs) have revolutionized multiple aspects of medicine by enabling novel
sensing, diagnostic, and therapeutic approaches. Advancements in processing and …

Engineered nanoparticles (NPs) have broad applications in industry and nanomedicine.
When NPs enter the body, interactions with the immune system are unavoidable. The innate …

Antibiotic resistance against infections caused by microbes has emerged as a global
challenge resulting in longer hospitalizations and higher medical cost and mortality. The …

Microbial infections present a major global healthcare challenge, in large part because of
the development of microbial resistance to the currently approved antimicrobial drugs. This …

Nanoparticles have emerged as a boon for the public health applications such as drug
delivery, diagnostic, and imaging. Biodegradable and non-bio degradable nanoparticles …

Nanotechnology has recently gained traction in the medical field as a method of targeted
delivery and timed release of therapeutic drugs. As interest in this field grows, design …

In this work, we present a simple and efficient method for pure phase magnetite (Fe3O4)
nanoparticle synthesis. The phase structure, particle shape, and size of the samples were …